Related references
Note: Only part of the references are listed.Factors associated with late risks of breast cancer-specific mortality in the SEER registry
Jose P. Leone et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Late Recurrences After Estrogen Receptor-Positive Breast Cancer
Steven A. Narod et al.
JAMA ONCOLOGY (2020)
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
Iris Noordhoek et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries
Rikke Norgaard Pedersen et al.
CLINICAL EPIDEMIOLOGY (2020)
A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy
Vasily Giannakeas et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The Danish health care system and epidemiological research: from health care contacts to database records
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2019)
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
Nancy Y. Yu et al.
JAMA ONCOLOGY (2019)
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations
Ryan J. O. Dowling et al.
JNCI CANCER SPECTRUM (2019)
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions
Ryan J. O. Dowling et al.
JNCI CANCER SPECTRUM (2019)
20-year risk of breast cancer recurrence
Karel Kostev et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Breast-Cancer Recurrence after Stopping Endocrine Therapy
Geoffrey M. Anderson
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016
Maj-Britt Jensen et al.
ACTA ONCOLOGICA (2018)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89TM cohort
C. D. Lyngholm et al.
ACTA ONCOLOGICA (2016)
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V
Marco Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Importance of Margin Width in Breast-Conserving Treatment of Early Breast Cancer
Anne Bodilsen et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients
Tinne Laurberg et al.
RADIOTHERAPY AND ONCOLOGY (2016)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
Cancer Metastases: Early Dissemination and Late Recurrences
Sten Friberg et al.
CANCER GROWTH AND METASTASIS (2015)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Incidence of metachronous contralateral breast cancer in Denmark 1978-2009
Christina Bording Rasmussen et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
The Impact of Re-Excision and Residual Disease on Local Recurrence After Breast Conservation Treatment for Patients With Early Stage Breast Cancer
Ahmed N. Ali et al.
CLINICAL BREAST CANCER (2011)
The Danish Register of Causes of Death
Karin Helweg-Larsen
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Tumor Cell Seeding During Surgery—Possible Contribution to Metastasis Formations
Pachmann Katharina
Cancers (2011)
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank
Erichsen
Clinical Epidemiology (2010)
Does tumour dormancy offer a therapeutic target?
Paul E. Goss et al.
NATURE REVIEWS CANCER (2010)
Recurrence pattern and prognosis in low-risk breast cancer patients - Data from the DBCG 89-A programme
Peer Christiansen et al.
ACTA ONCOLOGICA (2008)
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise
Susanne Moller et al.
ACTA ONCOLOGICA (2008)
Invasive lobular breast cancer. Prognostic significance of histological malignancy grading
Maj-Lis Moller Talman et al.
ACTA ONCOLOGICA (2007)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Validity and representativity in the Danish Breast Cancer Cooperative Group - A study on protocol allocation and data validity from one county to a multi-centre database
AR Jensen et al.
ACTA ONCOLOGICA (2003)
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
R Peto et al.
LANCET (2000)
Share Paper
